ClinicalTrials.Veeva

Menu

Methods of Post Operative Analgesia in Patients Undergoing Thyroidectomy

S

Sohag University

Status

Enrolling

Conditions

Thyroid Disorder

Treatments

Drug: group k : will receive Ketamine
Drug: group L : will receive lidocaine
Drug: group c: will recieve .9% saline

Study type

Interventional

Funder types

Other

Identifiers

NCT07045870
Soh-Med--25-6-11MS

Details and patient eligibility

About

this study aims to compare between effects of lidocaine and ketamine infusion on postoperative analgesia in patients undergoing thyroidectomy.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age from 18 to 75 years old
  • both sexes
  • scheduled for thyroidectomy

Exclusion criteria

  • toxic goiter
  • (BMI) exceeding 30 kg / m2
  • un controlled hypertension
  • sever liver or kidney disorders
  • allergy to study drugs
  • hyperthyroidism

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups, including a placebo group

group L : will receive lidocaine
Active Comparator group
Description:
lidocaine Infusion will be given for Postoperative Analgesia in Patients Undergoing Thyroidectomy
Treatment:
Drug: group L : will receive lidocaine
group k : will receive ketamine
Active Comparator group
Description:
Ketamine Infusion will be given for Postoperative Analgesia in Patients Undergoing Thyroidectomy
Treatment:
Drug: group k : will receive Ketamine
group c: will receive .9% saline
Placebo Comparator group
Description:
.9% saline will be given for Postoperative Analgesia in Patients Undergoing Thyroidectomy
Treatment:
Drug: group c: will recieve .9% saline

Trial contacts and locations

1

Loading...

Central trial contact

Abdel Rahman H Abdel Rahman, Professor; Mario N Ishak, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems